[{"NetIncomeLossConverted_1_Q1_USD":-37176000.0,"NetCashProvidedByUsedInOperatingActivitiesConverted_1_Q1_USD":-37246000.0,"CommonStockSharesOutstanding_0_Q1_shares":73435109.0,"StockholdersEquity_0_Q1_USD":722580000.0,"EarningsPerShareBasic_1_Q1_USD":-0.53,"RevenuesConverted_1_Q1_USD":10131000.0,"Assets_0_Q1_USD":811651000.0,"CommonStockSharesConverted_0_Q1_shares":73435109.0,"Ticker":"RVMD","CIK":"1628171","name":"REVOLUTION MEDICINES, INC.","OfficialName":"Revolution Medicines Inc. Common Stock","form":"10-Q","period":"20210331","fy":"2021.0","fp":"Q1","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"1775342076.0","Country":"United States","Sector":"Consumer Durables","Industry":"Specialty Chemicals","Market":"NASDAQ","SP500":"nan","filed":"20210510"}]